trending Market Intelligence /marketintelligence/en/news-insights/trending/2UbwVXUBTVWVIBXw_Q_3NQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Rox Resources mulls sale of interest in Reward zinc project for A$14.8M

Greenhouse gas and gold mines Nearly 1 ton of CO2 emitted per ounce of gold produced in 2019

Essential Metals & Mining Insights - September 2020

Essential Metals & Mining Insights - August 2020

State of the Market: Mining Q2-2020

Rox Resources mulls sale of interest in Reward zinc project for A$14.8M

IM Medical Ltd. subsidiary IMI Zinc Exploration Pty. Ltd.intends to acquire Rox ResourcesLtd.'s 30% interest in the Reward zinc-lead project in the Northern Territory,Australia, for A$14.8 million.

Rox has 30 days to complete due diligence on the offer,which comprises A$12.8 million in shares of IM Medical, and A$2.0 million incash. The offer will remain open until Aug. 17, Rox said July 19.

The offer is conditional upon Rox's joint venture partner,Teck Australia Pty.Ltd., waiving its pre-emptive right to the interest.

The sale also requires the signing of a formal agreement,shareholder and regulatory approvals, and IMI Zinc having liquid assets of atleast A$6 million.

According to the statement, IM Medical, which has beensuspended since Dec. 29, 2015, intends to seek reinstatement on the ASX and undertakea capital raising of up to A$12 million, provided that the transaction goesthrough.

As part of the capital raising, Rox has agreed to issue upto 240 million options, at a 3 Australian cents exercise price with athree-year term, to investors on the basis of 4 Rox options for every IMMedical share subscribed.